The JAK1/2 inhibitor ruxolitinib induces cell cycle arrest and apoptosis through inhibiting STAT3 phosphorylation in squamous cell carcinoma

被引：0
|
作者：
Jackow, J. [1 ]
Perez-Lorenzo, R. [1 ]
Hansen, C. [1 ]
Owens, D. [1 ]
Christiano, A. [1 ]
机构：
[1] Columbia Univ, Dermatol, New York, NY USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2018年 / 138卷 / 05期
关键词：
D O I：
10.1016/j.jid.2018.03.203
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
198
引用
收藏
页码：S34 / S34
页数：1
相关论文
共 50 条
  • [21] The JAK1/JAK2 Inhibitor Ruxolitinib Substantially Affects NK Cell Biology
    Schoenberg, Kathrin
    Rudolph, Janna
    Cornez, Isabelle
    Brossart, Peter
    Wolf, Dominik
    BLOOD, 2013, 122 (21)
  • [22] S-adenosylmethionine induces apoptosis and cycle arrest of gallbladder carcinoma cells by suppression of JAK2/STAT3 pathways
    Liu, Yan
    Bi, Tingting
    Yuan, Fukang
    Gao, Xinbao
    Jia, Gaolei
    Tian, Zhilong
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2020, 393 (12) : 2507 - 2515
  • [23] S-adenosylmethionine induces apoptosis and cycle arrest of gallbladder carcinoma cells by suppression of JAK2/STAT3 pathways
    Yan Liu
    Tingting Bi
    Fukang Yuan
    Xinbao Gao
    Gaolei Jia
    Zhilong Tian
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2020, 393 : 2507 - 2515
  • [24] RUXOLITINIB, A JAK1/JAK2 INHIBITOR, INHIBITS CELL PROLIFERATION AND INDUCES APOPTOSIS IN HODGKIN LYMPHOMA (HL) AND PRIMARY MEDIASTINAL B-CELL LYMPHOMA (PMBL)
    Yin, C.
    Ayello, J.
    Van de Ven, C.
    Lee, S.
    Cairo, M. S.
    PEDIATRIC BLOOD & CANCER, 2013, 60 : 154 - 154
  • [25] JAK1/JAK2 Inhibitor, Ruxolitinib Inhibits Cell Proliferation and Induces Apoptosis in Hodgkin Lymphomas (HL) and Primary Mediastinal B-Cell Lymphomas (PMBL)
    Yin, Changhong
    Lee, Sanghoon
    Ayello, Janet
    van de Ven, Carmella
    Pao, James
    Mulvey, Erin
    Cairo, Mitchell S.
    BLOOD, 2012, 120 (21)
  • [26] Ellagic acid induces esophageal squamous cell carcinoma cell apoptosis by modulating SHP-1/STAT3 signaling
    Xu, Ying-Ying
    Wang, Wan-Wei
    Huang, Jing
    Zhu, Wei-Guo
    KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2020, 36 (09): : 699 - 704
  • [27] Dihydroartemisinin as a Putative STAT3 Inhibitor, Suppresses the Growth of Head and Neck Squamous Cell Carcinoma by Targeting Jak2/STAT3 Signaling
    Jia, Lifeng
    Song, Qi
    Zhou, Chenyang
    Li, Xiaoming
    Pi, Lihong
    Ma, Xiuru
    Li, Hui
    Lu, Xiuying
    Shen, Yupeng
    PLOS ONE, 2016, 11 (01):
  • [28] Discovery and evaluation of Atopaxar hydrobromide, a novel JAK1 and JAK2 inhibitor, selectively induces apoptosis of cancer cells with constitutively activated STAT3
    Jingjie Sun
    Yuping Du
    Xinxin Zhang
    Zhuoya Wang
    Yuxi Lin
    Qiaoling Song
    Xiao Wang
    Jihui Guo
    Shanshan Li
    Jing Nan
    Jinbo Yang
    Investigational New Drugs, 2020, 38 : 1003 - 1011
  • [29] Discovery and evaluation of Atopaxar hydrobromide, a novel JAK1 and JAK2 inhibitor, selectively induces apoptosis of cancer cells with constitutively activated STAT3
    Sun, Jingjie
    Du, Yuping
    Zhang, Xinxin
    Wan, Zhuoya
    Lin, Yuxi
    Song, Qiaoling
    Wang, Xiao
    Guo, Jihui
    Li, Shanshan
    Nan, Jing
    Yang, Jinbo
    INVESTIGATIONAL NEW DRUGS, 2020, 38 (04) : 1003 - 1011
  • [30] The JAK1/JAK2-inhibitor ruxolitinib inhibits mast cell degranulation and cytokine release
    Hermans, Maud A. W.
    Schrijver, Benjamin
    van Holten-Neelen, Conny C. P. A.
    Gerth van Wijk, Roy
    van Hagen, P. Martin
    van Daele, Paul L. A.
    Dik, Willem A.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2018, 48 (11): : 1412 - 1420
12345